DWA
IDYA icon

Dorsey Wright & Associates’s IDEAYA Biosciences IDYA Stock Holding History

Dorsey Wright & Associates’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,484
Closed -$59K – 315
2021
Q4 		$59K Buy
2,484
+336
+16% +$7.8K 0.01% 202
2021
Q3 		$55K Buy
2,148
+168
+8% +$3.92K 0.01% 187
2021
Q2 		$42K Hold
1,980
– – 0.01% 239
2021
Q1 		$46.5K Buy
1,980
+1,137
+135% +$21.9K 0.55% 62
2020
Q4 		$12K Buy
+843
New +$11.4K ﹤0.01% 286

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Dorsey Wright & Associates's IDYA Position: Q1 2022 in Review

Dorsey Wright & Associates sold out of IDEAYA Biosciences (IDYA) in Q1 2022, closing a stake of 2,484 shares — an estimated $59K sold.

Dorsey Wright & Associates first reported a position in IDYA in Q4 2020 and held it in 5 quarters. The position peaked at $59K in Q4 2021. 103 funds tracked by Wall St. Rank hold IDYA as of Q1 2022.

  • Dorsey Wright & Associates reported no remaining IDEAYA Biosciences position as of Q1 2022 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,484 IDEAYA Biosciences shares in Q1 2022, an estimated $59K.
  • Dorsey Wright & Associates first reported a position in IDEAYA Biosciences in Q4 2020 and held it in 5 quarters.
  • Dorsey Wright & Associates's IDEAYA Biosciences position peaked at $59K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2022.

Based on Dorsey Wright & Associates's 13F filing for Q1 2022, filed 27 Apr 2022.